Literature DB >> 22748024

Polyanalgesic Consensus Conference 2012: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel.

Timothy R Deer1, Joshua Prager, Robert Levy, James Rathmell, Eric Buchser, Allen Burton, David Caraway, Michael Cousins, José De Andrés, Sudhir Diwan, Michael Erdek, Eric Grigsby, Marc Huntoon, Marilyn S Jacobs, Philip Kim, Krishna Kumar, Michael Leong, Liong Liem, Gladstone C McDowell, Sunil Panchal, Richard Rauck, Michael Saulino, B Todd Sitzman, Peter Staats, Michael Stanton-Hicks, Lisa Stearns, Mark Wallace, K Dean Willis, William Witt, Tony Yaksh, Nagy Mekhail.   

Abstract

INTRODUCTION: The use of intrathecal (IT) infusion of analgesic medications to treat patients with chronic refractory pain has increased since its inception in the 1980s, and the need for clinical research in IT therapy is ongoing. The Polyanalgesic Consensus Conference (PACC) panel of experts convened in 2000, 2003, and 2007 to make recommendations on the rational use of IT analgesics based on preclinical and clinical literature and clinical experiences.
METHODS: The PACC panel convened again in 2011 to update the standard of care for IT therapies to reflect current knowledge gleaned from literature and clinical experience. A thorough literature search was performed, and information from this search was provided to panel members. Analysis of published literature was coupled with the clinical experience of panel members to form recommendations regarding the use of IT analgesics to treat chronic pain.
RESULTS: After a review of literature published from 2007 to 2011 and discussions of clinical experience, the panel created updated algorithms for the rational use of IT medications for the treatment of neuropathic pain and nociceptive pain.
CONCLUSIONS: The advent of new algorithmic tracks for neuropathic and nociceptive pain is an important step in improving patient care. The panel encourages continued research and development, including the development of new drugs, devices, and safety recommendations to improve the care of patients with chronic pain.
© 2012 International Neuromodulation Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22748024     DOI: 10.1111/j.1525-1403.2012.00476.x

Source DB:  PubMed          Journal:  Neuromodulation        ISSN: 1094-7159


  46 in total

Review 1.  Intrathecal Analgesia for Chronic Refractory Pain: Current and Future Prospects.

Authors:  Catherine Smyth; Nadera Ahmadzai; Jason Wentzell; Ashley Pardoe; Andrew Tse; Tiffany Nguyen; Yvette Goddard; Shona Nair; Patricia A Poulin; Becky Skidmore; Mohammed T Ansari
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

Review 2.  Intrathecal therapy for chronic pain: current trends and future needs.

Authors:  Salim M Hayek; Michael C Hanes
Journal:  Curr Pain Headache Rep       Date:  2014-01

Review 3.  Intrathecal ziconotide: a review of its use in patients with chronic pain refractory to other systemic or intrathecal analgesics.

Authors:  Mark Sanford
Journal:  CNS Drugs       Date:  2013-11       Impact factor: 5.749

Review 4.  Considerations for evaluating the use of intrathecal drug delivery in the oncologic patient.

Authors:  Amitabh Gulati; Vinay Puttanniah; Joseph Hung; Vivek Malhotra
Journal:  Curr Pain Headache Rep       Date:  2014-02

Review 5.  History and present state of targeted intrathecal drug delivery.

Authors:  Syed Rizvi; Krishna Kumar
Journal:  Curr Pain Headache Rep       Date:  2015

Review 6.  Intrathecal drug delivery for chronic pain management-scope, limitations and future.

Authors:  M Czernicki; G Sinovich; I Mihaylov; B Nejad; S Kunnumpurath; G Kodumudi; N Vadivelu
Journal:  J Clin Monit Comput       Date:  2014-08-31       Impact factor: 2.502

Review 7.  Recent progress in pancreatic cancer.

Authors:  Christopher L Wolfgang; Joseph M Herman; Daniel A Laheru; Alison P Klein; Michael A Erdek; Elliot K Fishman; Ralph H Hruban
Journal:  CA Cancer J Clin       Date:  2013-07-15       Impact factor: 508.702

Review 8.  Managing intrathecal drug delivery (ITDD) in cancer patients.

Authors:  Rajiv Shah; Aisha Baqai-Stern; Amitabh Gulati
Journal:  Curr Pain Headache Rep       Date:  2015-06

9.  Intrathecal Drug Delivery Systems for Cancer Pain: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2016-01-29

10.  Intrathecal Drug Delivery Systems for Noncancer Pain: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2016-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.